nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymorphone—OPRK1—Progesterone—uterine cancer	0.475	0.618	CbGbCtD
Oxymorphone—CYP2D6—Progesterone—uterine cancer	0.0868	0.113	CbGbCtD
Oxymorphone—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0834	0.108	CbGbCtD
Oxymorphone—CYP3A4—Progesterone—uterine cancer	0.0552	0.0718	CbGbCtD
Oxymorphone—CYP2D6—Doxorubicin—uterine cancer	0.0265	0.0345	CbGbCtD
Oxymorphone—CYP3A4—Etoposide—uterine cancer	0.0247	0.0321	CbGbCtD
Oxymorphone—CYP3A4—Doxorubicin—uterine cancer	0.0169	0.0219	CbGbCtD
Oxymorphone—Shock—Medroxyprogesterone Acetate—uterine cancer	0.000784	0.0034	CcSEcCtD
Oxymorphone—Somnolence—Progesterone—uterine cancer	0.000782	0.00339	CcSEcCtD
Oxymorphone—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.000782	0.00338	CcSEcCtD
Oxymorphone—Bronchospasm—Etoposide—uterine cancer	0.000779	0.00337	CcSEcCtD
Oxymorphone—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.000778	0.00337	CcSEcCtD
Oxymorphone—Dyspepsia—Progesterone—uterine cancer	0.000774	0.00335	CcSEcCtD
Oxymorphone—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000774	0.00335	CcSEcCtD
Oxymorphone—Sweating increased—Etoposide—uterine cancer	0.000771	0.00334	CcSEcCtD
Oxymorphone—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.000771	0.00334	CcSEcCtD
Oxymorphone—Oliguria—Epirubicin—uterine cancer	0.000767	0.00332	CcSEcCtD
Oxymorphone—Decreased appetite—Progesterone—uterine cancer	0.000765	0.00331	CcSEcCtD
Oxymorphone—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00076	0.00329	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Progesterone—uterine cancer	0.00076	0.00329	CcSEcCtD
Oxymorphone—Fatigue—Progesterone—uterine cancer	0.000759	0.00328	CcSEcCtD
Oxymorphone—Pain—Progesterone—uterine cancer	0.000752	0.00326	CcSEcCtD
Oxymorphone—Constipation—Progesterone—uterine cancer	0.000752	0.00326	CcSEcCtD
Oxymorphone—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000745	0.00323	CcSEcCtD
Oxymorphone—Feeling abnormal—Progesterone—uterine cancer	0.000725	0.00314	CcSEcCtD
Oxymorphone—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000721	0.00312	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Progesterone—uterine cancer	0.000719	0.00311	CcSEcCtD
Oxymorphone—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000711	0.00308	CcSEcCtD
Oxymorphone—Oliguria—Doxorubicin—uterine cancer	0.00071	0.00307	CcSEcCtD
Oxymorphone—Pneumonia—Etoposide—uterine cancer	0.00071	0.00307	CcSEcCtD
Oxymorphone—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000709	0.00307	CcSEcCtD
Oxymorphone—Injection site reaction—Epirubicin—uterine cancer	0.000703	0.00304	CcSEcCtD
Oxymorphone—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000702	0.00304	CcSEcCtD
Oxymorphone—Urticaria—Progesterone—uterine cancer	0.000699	0.00303	CcSEcCtD
Oxymorphone—Body temperature increased—Progesterone—uterine cancer	0.000696	0.00301	CcSEcCtD
Oxymorphone—Abdominal pain—Progesterone—uterine cancer	0.000696	0.00301	CcSEcCtD
Oxymorphone—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000693	0.003	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000688	0.00298	CcSEcCtD
Oxymorphone—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000687	0.00298	CcSEcCtD
Oxymorphone—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000682	0.00295	CcSEcCtD
Oxymorphone—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000657	0.00284	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000652	0.00282	CcSEcCtD
Oxymorphone—Injection site reaction—Doxorubicin—uterine cancer	0.00065	0.00282	CcSEcCtD
Oxymorphone—Hypersensitivity—Progesterone—uterine cancer	0.000648	0.00281	CcSEcCtD
Oxymorphone—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000633	0.00274	CcSEcCtD
Oxymorphone—Asthenia—Progesterone—uterine cancer	0.000631	0.00273	CcSEcCtD
Oxymorphone—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00063	0.00273	CcSEcCtD
Oxymorphone—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00063	0.00273	CcSEcCtD
Oxymorphone—Urinary tract disorder—Etoposide—uterine cancer	0.000626	0.00271	CcSEcCtD
Oxymorphone—Pruritus—Progesterone—uterine cancer	0.000622	0.00269	CcSEcCtD
Oxymorphone—Oedema—Dactinomycin—uterine cancer	0.000622	0.00269	CcSEcCtD
Oxymorphone—Urethral disorder—Etoposide—uterine cancer	0.000621	0.00269	CcSEcCtD
Oxymorphone—Mental disability—Epirubicin—uterine cancer	0.000614	0.00266	CcSEcCtD
Oxymorphone—Diarrhoea—Progesterone—uterine cancer	0.000602	0.00261	CcSEcCtD
Oxymorphone—Anorexia—Dactinomycin—uterine cancer	0.000593	0.00257	CcSEcCtD
Oxymorphone—Eye disorder—Etoposide—uterine cancer	0.000592	0.00256	CcSEcCtD
Oxymorphone—Cardiac disorder—Etoposide—uterine cancer	0.000588	0.00255	CcSEcCtD
Oxymorphone—Flushing—Etoposide—uterine cancer	0.000588	0.00255	CcSEcCtD
Oxymorphone—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000587	0.00254	CcSEcCtD
Oxymorphone—Dizziness—Progesterone—uterine cancer	0.000582	0.00252	CcSEcCtD
Oxymorphone—Angiopathy—Etoposide—uterine cancer	0.000575	0.00249	CcSEcCtD
Oxymorphone—Immune system disorder—Etoposide—uterine cancer	0.000572	0.00248	CcSEcCtD
Oxymorphone—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000572	0.00248	CcSEcCtD
Oxymorphone—Mediastinal disorder—Etoposide—uterine cancer	0.000571	0.00247	CcSEcCtD
Oxymorphone—Mental disability—Doxorubicin—uterine cancer	0.000568	0.00246	CcSEcCtD
Oxymorphone—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000564	0.00244	CcSEcCtD
Oxymorphone—Vomiting—Progesterone—uterine cancer	0.000559	0.00242	CcSEcCtD
Oxymorphone—Dermatitis—Progesterone—uterine cancer	0.000554	0.0024	CcSEcCtD
Oxymorphone—Headache—Progesterone—uterine cancer	0.000551	0.00239	CcSEcCtD
Oxymorphone—Hot flush—Epirubicin—uterine cancer	0.000549	0.00238	CcSEcCtD
Oxymorphone—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000546	0.00236	CcSEcCtD
Oxymorphone—Menopausal symptoms—Epirubicin—uterine cancer	0.000544	0.00236	CcSEcCtD
Oxymorphone—Decreased appetite—Dactinomycin—uterine cancer	0.000541	0.00234	CcSEcCtD
Oxymorphone—Fatigue—Dactinomycin—uterine cancer	0.000536	0.00232	CcSEcCtD
Oxymorphone—Pain—Dactinomycin—uterine cancer	0.000532	0.0023	CcSEcCtD
Oxymorphone—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000527	0.00228	CcSEcCtD
Oxymorphone—Lethargy—Epirubicin—uterine cancer	0.000524	0.00227	CcSEcCtD
Oxymorphone—Nausea—Progesterone—uterine cancer	0.000523	0.00226	CcSEcCtD
Oxymorphone—Diplopia—Epirubicin—uterine cancer	0.000513	0.00222	CcSEcCtD
Oxymorphone—Feeling abnormal—Dactinomycin—uterine cancer	0.000512	0.00222	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000509	0.0022	CcSEcCtD
Oxymorphone—Hot flush—Doxorubicin—uterine cancer	0.000508	0.0022	CcSEcCtD
Oxymorphone—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000507	0.00219	CcSEcCtD
Oxymorphone—Menopausal symptoms—Doxorubicin—uterine cancer	0.000503	0.00218	CcSEcCtD
Oxymorphone—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000502	0.00217	CcSEcCtD
Oxymorphone—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000499	0.00216	CcSEcCtD
Oxymorphone—Vertigo—Etoposide—uterine cancer	0.000495	0.00215	CcSEcCtD
Oxymorphone—Abdominal pain—Dactinomycin—uterine cancer	0.000492	0.00213	CcSEcCtD
Oxymorphone—Body temperature increased—Dactinomycin—uterine cancer	0.000492	0.00213	CcSEcCtD
Oxymorphone—Loss of consciousness—Etoposide—uterine cancer	0.000485	0.0021	CcSEcCtD
Oxymorphone—Lethargy—Doxorubicin—uterine cancer	0.000485	0.0021	CcSEcCtD
Oxymorphone—Convulsion—Etoposide—uterine cancer	0.000478	0.00207	CcSEcCtD
Oxymorphone—Dehydration—Epirubicin—uterine cancer	0.000477	0.00207	CcSEcCtD
Oxymorphone—Hypertension—Etoposide—uterine cancer	0.000476	0.00206	CcSEcCtD
Oxymorphone—Diplopia—Doxorubicin—uterine cancer	0.000475	0.00206	CcSEcCtD
Oxymorphone—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000474	0.00205	CcSEcCtD
Oxymorphone—Chest pain—Etoposide—uterine cancer	0.00047	0.00203	CcSEcCtD
Oxymorphone—Orthostatic hypotension—Epirubicin—uterine cancer	0.000469	0.00203	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000466	0.00202	CcSEcCtD
Oxymorphone—Hypersensitivity—Dactinomycin—uterine cancer	0.000458	0.00198	CcSEcCtD
Oxymorphone—Confusional state—Etoposide—uterine cancer	0.000454	0.00196	CcSEcCtD
Oxymorphone—Abdominal distension—Epirubicin—uterine cancer	0.000447	0.00193	CcSEcCtD
Oxymorphone—Asthenia—Dactinomycin—uterine cancer	0.000446	0.00193	CcSEcCtD
Oxymorphone—Dehydration—Doxorubicin—uterine cancer	0.000442	0.00191	CcSEcCtD
Oxymorphone—Tachycardia—Etoposide—uterine cancer	0.000439	0.0019	CcSEcCtD
Oxymorphone—Skin disorder—Etoposide—uterine cancer	0.000437	0.00189	CcSEcCtD
Oxymorphone—Hyperhidrosis—Etoposide—uterine cancer	0.000435	0.00188	CcSEcCtD
Oxymorphone—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000434	0.00188	CcSEcCtD
Oxymorphone—Anorexia—Etoposide—uterine cancer	0.000429	0.00186	CcSEcCtD
Oxymorphone—Diarrhoea—Dactinomycin—uterine cancer	0.000425	0.00184	CcSEcCtD
Oxymorphone—Hypotension—Etoposide—uterine cancer	0.000421	0.00182	CcSEcCtD
Oxymorphone—Abdominal distension—Doxorubicin—uterine cancer	0.000413	0.00179	CcSEcCtD
Oxymorphone—Weight decreased—Epirubicin—uterine cancer	0.000401	0.00174	CcSEcCtD
Oxymorphone—Dyspnoea—Etoposide—uterine cancer	0.000401	0.00174	CcSEcCtD
Oxymorphone—Somnolence—Etoposide—uterine cancer	0.0004	0.00173	CcSEcCtD
Oxymorphone—Pneumonia—Epirubicin—uterine cancer	0.000398	0.00172	CcSEcCtD
Oxymorphone—Vomiting—Dactinomycin—uterine cancer	0.000395	0.00171	CcSEcCtD
Oxymorphone—Decreased appetite—Etoposide—uterine cancer	0.000391	0.00169	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Etoposide—uterine cancer	0.000389	0.00168	CcSEcCtD
Oxymorphone—Fatigue—Etoposide—uterine cancer	0.000388	0.00168	CcSEcCtD
Oxymorphone—Pain—Etoposide—uterine cancer	0.000385	0.00167	CcSEcCtD
Oxymorphone—Constipation—Etoposide—uterine cancer	0.000385	0.00167	CcSEcCtD
Oxymorphone—Weight decreased—Doxorubicin—uterine cancer	0.000371	0.00161	CcSEcCtD
Oxymorphone—Feeling abnormal—Etoposide—uterine cancer	0.000371	0.00161	CcSEcCtD
Oxymorphone—Nausea—Dactinomycin—uterine cancer	0.000369	0.0016	CcSEcCtD
Oxymorphone—Pneumonia—Doxorubicin—uterine cancer	0.000368	0.00159	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Etoposide—uterine cancer	0.000368	0.00159	CcSEcCtD
Oxymorphone—Bradycardia—Epirubicin—uterine cancer	0.000362	0.00157	CcSEcCtD
Oxymorphone—Urticaria—Etoposide—uterine cancer	0.000358	0.00155	CcSEcCtD
Oxymorphone—Body temperature increased—Etoposide—uterine cancer	0.000356	0.00154	CcSEcCtD
Oxymorphone—Abdominal pain—Etoposide—uterine cancer	0.000356	0.00154	CcSEcCtD
Oxymorphone—Urinary tract disorder—Epirubicin—uterine cancer	0.000351	0.00152	CcSEcCtD
Oxymorphone—Urethral disorder—Epirubicin—uterine cancer	0.000348	0.00151	CcSEcCtD
Oxymorphone—Visual impairment—Epirubicin—uterine cancer	0.000342	0.00148	CcSEcCtD
Oxymorphone—Bradycardia—Doxorubicin—uterine cancer	0.000335	0.00145	CcSEcCtD
Oxymorphone—Eye disorder—Epirubicin—uterine cancer	0.000332	0.00144	CcSEcCtD
Oxymorphone—Hypersensitivity—Etoposide—uterine cancer	0.000332	0.00144	CcSEcCtD
Oxymorphone—Cardiac disorder—Epirubicin—uterine cancer	0.00033	0.00143	CcSEcCtD
Oxymorphone—Flushing—Epirubicin—uterine cancer	0.00033	0.00143	CcSEcCtD
Oxymorphone—Urinary tract disorder—Doxorubicin—uterine cancer	0.000324	0.0014	CcSEcCtD
Oxymorphone—Asthenia—Etoposide—uterine cancer	0.000323	0.0014	CcSEcCtD
Oxymorphone—Angiopathy—Epirubicin—uterine cancer	0.000322	0.00139	CcSEcCtD
Oxymorphone—Urethral disorder—Doxorubicin—uterine cancer	0.000322	0.00139	CcSEcCtD
Oxymorphone—Immune system disorder—Epirubicin—uterine cancer	0.000321	0.00139	CcSEcCtD
Oxymorphone—Mediastinal disorder—Epirubicin—uterine cancer	0.00032	0.00139	CcSEcCtD
Oxymorphone—Pruritus—Etoposide—uterine cancer	0.000318	0.00138	CcSEcCtD
Oxymorphone—Visual impairment—Doxorubicin—uterine cancer	0.000317	0.00137	CcSEcCtD
Oxymorphone—Mental disorder—Epirubicin—uterine cancer	0.000311	0.00135	CcSEcCtD
Oxymorphone—Malnutrition—Epirubicin—uterine cancer	0.000309	0.00134	CcSEcCtD
Oxymorphone—Diarrhoea—Etoposide—uterine cancer	0.000308	0.00133	CcSEcCtD
Oxymorphone—Eye disorder—Doxorubicin—uterine cancer	0.000307	0.00133	CcSEcCtD
Oxymorphone—Flushing—Doxorubicin—uterine cancer	0.000305	0.00132	CcSEcCtD
Oxymorphone—Cardiac disorder—Doxorubicin—uterine cancer	0.000305	0.00132	CcSEcCtD
Oxymorphone—Flatulence—Epirubicin—uterine cancer	0.000305	0.00132	CcSEcCtD
Oxymorphone—Tension—Epirubicin—uterine cancer	0.000303	0.00131	CcSEcCtD
Oxymorphone—Nervousness—Epirubicin—uterine cancer	0.0003	0.0013	CcSEcCtD
Oxymorphone—Angiopathy—Doxorubicin—uterine cancer	0.000298	0.00129	CcSEcCtD
Oxymorphone—Dizziness—Etoposide—uterine cancer	0.000298	0.00129	CcSEcCtD
Oxymorphone—Immune system disorder—Doxorubicin—uterine cancer	0.000297	0.00128	CcSEcCtD
Oxymorphone—Mediastinal disorder—Doxorubicin—uterine cancer	0.000296	0.00128	CcSEcCtD
Oxymorphone—Vision blurred—Epirubicin—uterine cancer	0.000291	0.00126	CcSEcCtD
Oxymorphone—Mental disorder—Doxorubicin—uterine cancer	0.000288	0.00125	CcSEcCtD
Oxymorphone—Vomiting—Etoposide—uterine cancer	0.000286	0.00124	CcSEcCtD
Oxymorphone—Malnutrition—Doxorubicin—uterine cancer	0.000286	0.00124	CcSEcCtD
Oxymorphone—Agitation—Epirubicin—uterine cancer	0.000284	0.00123	CcSEcCtD
Oxymorphone—Dermatitis—Etoposide—uterine cancer	0.000284	0.00123	CcSEcCtD
Oxymorphone—Headache—Etoposide—uterine cancer	0.000282	0.00122	CcSEcCtD
Oxymorphone—Flatulence—Doxorubicin—uterine cancer	0.000282	0.00122	CcSEcCtD
Oxymorphone—Tension—Doxorubicin—uterine cancer	0.000281	0.00122	CcSEcCtD
Oxymorphone—Nervousness—Doxorubicin—uterine cancer	0.000278	0.0012	CcSEcCtD
Oxymorphone—Vertigo—Epirubicin—uterine cancer	0.000278	0.0012	CcSEcCtD
Oxymorphone—Syncope—Epirubicin—uterine cancer	0.000277	0.0012	CcSEcCtD
Oxymorphone—Palpitations—Epirubicin—uterine cancer	0.000273	0.00118	CcSEcCtD
Oxymorphone—Loss of consciousness—Epirubicin—uterine cancer	0.000272	0.00118	CcSEcCtD
Oxymorphone—Vision blurred—Doxorubicin—uterine cancer	0.00027	0.00117	CcSEcCtD
Oxymorphone—Convulsion—Epirubicin—uterine cancer	0.000268	0.00116	CcSEcCtD
Oxymorphone—Nausea—Etoposide—uterine cancer	0.000267	0.00116	CcSEcCtD
Oxymorphone—Hypertension—Epirubicin—uterine cancer	0.000267	0.00116	CcSEcCtD
Oxymorphone—Chest pain—Epirubicin—uterine cancer	0.000263	0.00114	CcSEcCtD
Oxymorphone—Agitation—Doxorubicin—uterine cancer	0.000263	0.00114	CcSEcCtD
Oxymorphone—Anxiety—Epirubicin—uterine cancer	0.000262	0.00114	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000261	0.00113	CcSEcCtD
Oxymorphone—Dry mouth—Epirubicin—uterine cancer	0.000257	0.00111	CcSEcCtD
Oxymorphone—Vertigo—Doxorubicin—uterine cancer	0.000257	0.00111	CcSEcCtD
Oxymorphone—Syncope—Doxorubicin—uterine cancer	0.000257	0.00111	CcSEcCtD
Oxymorphone—Confusional state—Epirubicin—uterine cancer	0.000254	0.0011	CcSEcCtD
Oxymorphone—Palpitations—Doxorubicin—uterine cancer	0.000253	0.00109	CcSEcCtD
Oxymorphone—Oedema—Epirubicin—uterine cancer	0.000252	0.00109	CcSEcCtD
Oxymorphone—Loss of consciousness—Doxorubicin—uterine cancer	0.000251	0.00109	CcSEcCtD
Oxymorphone—Shock—Epirubicin—uterine cancer	0.000248	0.00107	CcSEcCtD
Oxymorphone—Convulsion—Doxorubicin—uterine cancer	0.000248	0.00107	CcSEcCtD
Oxymorphone—Nervous system disorder—Epirubicin—uterine cancer	0.000247	0.00107	CcSEcCtD
Oxymorphone—Hypertension—Doxorubicin—uterine cancer	0.000247	0.00107	CcSEcCtD
Oxymorphone—Tachycardia—Epirubicin—uterine cancer	0.000246	0.00107	CcSEcCtD
Oxymorphone—Skin disorder—Epirubicin—uterine cancer	0.000245	0.00106	CcSEcCtD
Oxymorphone—Hyperhidrosis—Epirubicin—uterine cancer	0.000244	0.00106	CcSEcCtD
Oxymorphone—Chest pain—Doxorubicin—uterine cancer	0.000244	0.00105	CcSEcCtD
Oxymorphone—Anxiety—Doxorubicin—uterine cancer	0.000243	0.00105	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000242	0.00105	CcSEcCtD
Oxymorphone—Anorexia—Epirubicin—uterine cancer	0.00024	0.00104	CcSEcCtD
Oxymorphone—Dry mouth—Doxorubicin—uterine cancer	0.000238	0.00103	CcSEcCtD
Oxymorphone—Hypotension—Epirubicin—uterine cancer	0.000236	0.00102	CcSEcCtD
Oxymorphone—Confusional state—Doxorubicin—uterine cancer	0.000235	0.00102	CcSEcCtD
Oxymorphone—Oedema—Doxorubicin—uterine cancer	0.000233	0.00101	CcSEcCtD
Oxymorphone—Shock—Doxorubicin—uterine cancer	0.00023	0.000994	CcSEcCtD
Oxymorphone—Nervous system disorder—Doxorubicin—uterine cancer	0.000229	0.000991	CcSEcCtD
Oxymorphone—Insomnia—Epirubicin—uterine cancer	0.000228	0.000988	CcSEcCtD
Oxymorphone—Tachycardia—Doxorubicin—uterine cancer	0.000228	0.000986	CcSEcCtD
Oxymorphone—Skin disorder—Doxorubicin—uterine cancer	0.000227	0.000982	CcSEcCtD
Oxymorphone—Hyperhidrosis—Doxorubicin—uterine cancer	0.000226	0.000977	CcSEcCtD
Oxymorphone—Dyspnoea—Epirubicin—uterine cancer	0.000225	0.000974	CcSEcCtD
Oxymorphone—Somnolence—Epirubicin—uterine cancer	0.000224	0.000971	CcSEcCtD
Oxymorphone—Naloxone—ESR1—uterine cancer	0.000223	1	CrCbGaD
Oxymorphone—Anorexia—Doxorubicin—uterine cancer	0.000223	0.000963	CcSEcCtD
Oxymorphone—Dyspepsia—Epirubicin—uterine cancer	0.000222	0.000961	CcSEcCtD
Oxymorphone—Decreased appetite—Epirubicin—uterine cancer	0.000219	0.000949	CcSEcCtD
Oxymorphone—Hypotension—Doxorubicin—uterine cancer	0.000218	0.000944	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000218	0.000943	CcSEcCtD
Oxymorphone—Fatigue—Epirubicin—uterine cancer	0.000218	0.000942	CcSEcCtD
Oxymorphone—Constipation—Epirubicin—uterine cancer	0.000216	0.000934	CcSEcCtD
Oxymorphone—Pain—Epirubicin—uterine cancer	0.000216	0.000934	CcSEcCtD
Oxymorphone—Insomnia—Doxorubicin—uterine cancer	0.000211	0.000914	CcSEcCtD
Oxymorphone—Dyspnoea—Doxorubicin—uterine cancer	0.000208	0.000901	CcSEcCtD
Oxymorphone—Feeling abnormal—Epirubicin—uterine cancer	0.000208	0.0009	CcSEcCtD
Oxymorphone—Somnolence—Doxorubicin—uterine cancer	0.000208	0.000898	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Epirubicin—uterine cancer	0.000206	0.000893	CcSEcCtD
Oxymorphone—Dyspepsia—Doxorubicin—uterine cancer	0.000205	0.00089	CcSEcCtD
Oxymorphone—Decreased appetite—Doxorubicin—uterine cancer	0.000203	0.000879	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000202	0.000873	CcSEcCtD
Oxymorphone—Fatigue—Doxorubicin—uterine cancer	0.000201	0.000871	CcSEcCtD
Oxymorphone—Urticaria—Epirubicin—uterine cancer	0.0002	0.000868	CcSEcCtD
Oxymorphone—Constipation—Doxorubicin—uterine cancer	0.0002	0.000864	CcSEcCtD
Oxymorphone—Pain—Doxorubicin—uterine cancer	0.0002	0.000864	CcSEcCtD
Oxymorphone—Abdominal pain—Epirubicin—uterine cancer	0.000199	0.000863	CcSEcCtD
Oxymorphone—Body temperature increased—Epirubicin—uterine cancer	0.000199	0.000863	CcSEcCtD
Oxymorphone—Feeling abnormal—Doxorubicin—uterine cancer	0.000192	0.000833	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000191	0.000826	CcSEcCtD
Oxymorphone—Hypersensitivity—Epirubicin—uterine cancer	0.000186	0.000805	CcSEcCtD
Oxymorphone—Urticaria—Doxorubicin—uterine cancer	0.000185	0.000803	CcSEcCtD
Oxymorphone—Abdominal pain—Doxorubicin—uterine cancer	0.000185	0.000799	CcSEcCtD
Oxymorphone—Body temperature increased—Doxorubicin—uterine cancer	0.000185	0.000799	CcSEcCtD
Oxymorphone—Asthenia—Epirubicin—uterine cancer	0.000181	0.000784	CcSEcCtD
Oxymorphone—Pruritus—Epirubicin—uterine cancer	0.000178	0.000773	CcSEcCtD
Oxymorphone—Diarrhoea—Epirubicin—uterine cancer	0.000173	0.000747	CcSEcCtD
Oxymorphone—Hypersensitivity—Doxorubicin—uterine cancer	0.000172	0.000745	CcSEcCtD
Oxymorphone—Asthenia—Doxorubicin—uterine cancer	0.000167	0.000725	CcSEcCtD
Oxymorphone—Dizziness—Epirubicin—uterine cancer	0.000167	0.000722	CcSEcCtD
Oxymorphone—Pruritus—Doxorubicin—uterine cancer	0.000165	0.000715	CcSEcCtD
Oxymorphone—Vomiting—Epirubicin—uterine cancer	0.00016	0.000694	CcSEcCtD
Oxymorphone—Diarrhoea—Doxorubicin—uterine cancer	0.00016	0.000691	CcSEcCtD
Oxymorphone—Dermatitis—Epirubicin—uterine cancer	0.000159	0.000688	CcSEcCtD
Oxymorphone—Headache—Epirubicin—uterine cancer	0.000158	0.000684	CcSEcCtD
Oxymorphone—Dizziness—Doxorubicin—uterine cancer	0.000154	0.000668	CcSEcCtD
Oxymorphone—Nausea—Epirubicin—uterine cancer	0.00015	0.000649	CcSEcCtD
Oxymorphone—Vomiting—Doxorubicin—uterine cancer	0.000148	0.000643	CcSEcCtD
Oxymorphone—Dermatitis—Doxorubicin—uterine cancer	0.000147	0.000637	CcSEcCtD
Oxymorphone—Headache—Doxorubicin—uterine cancer	0.000146	0.000633	CcSEcCtD
Oxymorphone—Nausea—Doxorubicin—uterine cancer	0.000139	0.0006	CcSEcCtD
